DLA Piper LLP (US) is recognized for its ‘subject matter expertise’ in cannabis and hemp, covering regulatory, corporate, litigation, and government affairs matters across the full business lifecycle. The firm supports a wide range of clients - from multinational consumer goods companies and publicly traded multi-state operators to startups and private equity investors - and is particularly well regarded for its M&A, corporate structuring, capital markets, and securities compliance work. Both based in Boston, practice co-heads
Stefanie Fogel and
Maggie Craig cover a broad range of matters, with Fogel working with multinationals and startups in the hemp-based CBD product space on regulation, compliance, and litigation, while Craig draws on her regulatory expertise to mitigate risks across the cannabis, hemp, and CBD supply chain. Fellow practice head
Christopher Giordano concentrates on M&A and corporate matters for private and publicly traded cannabis and wellness companies.
Sharon Mayl brings valuable insight from her former experience at the FDA, advising on the legal requirements for the development, manufacturing, and marketing of cannabis products.